Week 10: Therapy for Clients with Dementia

In so many countries, to be old is shameful; to be
mentally ill as well as old is doubly shameful. In so many countries,
people with elderly relatives who are also mentally ill are ashamed and
try to hide what they see as a disgrace on the family.

—Dr. Nori Graham, psychiatrist and honorary vice president of Alzheimer’s Disease International

In this quote, Dr. Graham is expressing her
observations and experiences in her work with numerous international
organizations. Many patients and their families experience feelings of
anxiety and shame upon receiving a diagnosis of dementia. Lynda Hogg, an
Alzheimer’s patient, shares her feelings that “some people don’t want
to be associated with someone with an illness affecting the brain”
(Alzheimer’s Disease International, 2012). As a psychiatric mental
health nurse practitioner providing care to clients presenting with
dementia, it is critically important to consider the impact of these
disorders on clients, caregivers, and their families. A thorough
understanding of the health implications of these disorders, as well as
each client’s personal concerns, will aid you in making effective
treatment and management decisions.

This
week, you explore strategies to become a social change agent for
psychiatric mental health. Then, as you examine the assessment and
treatment of clients with dementia, you also consider related ethical
and legal implications.

Discussion: Influencing Social Change

Individuals with psychiatric mental health
disorders are frequently stigmatized not only by society as a whole, but
also by their friends, family, and sometimes healthcare providers. In
your role, however, you have the opportunity to become a social change
agent for these individuals. For this Discussion, consider how you might
make a positive impact for your clients and advocate for social change
within your own community.

Learning Objectives

Students will:

• Apply strategies to become a social change agent for psychiatric mental health

Learning Resources

Note: To access this week’s required library resources, please click on the link to the Course Readings List, found in the Course Materials section of your Syllabus.

Required Readings

Angermeyer, M. C., Matschinger, H., & Schomerus, G. (2013). Attitudes towards psychiatric treatment and people with mental illness: Changes over two decades. The British Journal of Psychiatry, 203(2), 146–151. Retrieved from http://bjp.rcpsych.org/content/203/2/146.full

Bui, Q. (2012). Antidepressants for agitation and psychosis in patients with dementia. American Family Physician, 85(1), 20-22.

Dingfelder, S. F. (2009). Stigma: Alive and well. American Psychological Association, 40(6), 56. Retrieved from http://www.apa.org/monitor/2009/06/stigma.aspx

Jenkins, J. H. (2012). The anthropology of psychopharmacology: Commentary on contributions to the analysis of pharmaceutical self and imaginary. Culture, Medicine and Psychiatry, 36(1), 78-79. doi:10.1007/s11013-012-9248-0

Price, L. H. (2010). Violence in America: Is psychopharmacology the answer? Brown University Psychopharmacology Update, 21(5), 5.

Optional Resources

Bennett, T. (2015). Changing the way society understands mental health. National Alliance on Mental Illness. Retrieved from http://www.nami.org/Blogs/NAMI-Blog/April-2015/Changing-The-Way-Society-Understands-Mental-Health

Mechanic, D. (2007). Mental health services then and now. Health Affairs, 26(6), 1548–1550. Retrieved from https://web.archive.org/web/20170605094514/http://content.healthaffairs.org/content/26/6/1548.full

Rothman, D. J. (1994). Shiny, happy people: The problem with “cosmetic psychopharmacology.” New Republic, 210(7), 34–38.

To prepare for this Discussion:

• Reflect on how you might influence social change for psychiatric mental health.

Note: For this Discussion, you are required to complete
your initial post before you will be able to view and respond to your
colleagues’ postings. Begin by clicking on the “Post to Discussion
Question” link and then select “Create Thread” to complete your initial
post. Remember, once you click on Submit, you cannot delete or edit your
own posts, and you cannot post anonymously. Please check your post
carefully before clicking on Submit!

By Day 3

Post an explanation of how you,
as a nurse practitioner, might become a social change agent for
psychiatric mental health. Include how you might advocate for change
within your own community.

Read a selection of your colleagues’ responses.

By Day 6

Respond to at least two of your colleagues by providing additional insights or alternative perspectives.

Submission and Grading Information

Grading Criteria

To access your rubric:Week 10 Discussion Rubric

Post by Day 3 and Respond by Day 6

To participate in this Discussion:Week 10 Discussion

Assignment: Assessing and Treating Clients With Dementia

The Alzheimer’s Association defines dementia as
“a general term for a decline in mental ability severe enough to
interfere with daily life” (Alzheimer’s Association, 2016). This term
encompasses dozens of cognitive disorders of impaired memory formation,
recall, and communication. The care and treatment of clients with
dementia is dependent on multiple factors, including the stage of
dementia, comorbidities, family support, and even the care setting. In
your role, as the psychiatric mental health nurse practitioner, you must
be prepared to not only treat clients with these various cognitive
disorders, but also the multiple behavioral issues that often accompany
them. For this Assignment, as you examine the client case study in this
week’s Learning Resources, consider how you might assess and treat
clients presenting with dementia.

Learning Objectives

Students will:

• Assess client factors and history to develop personalized therapy plans for clients with dementia
• Analyze factors that influence pharmacokinetic and pharmacodynamic processes in clients requiring therapy for dementia
• Evaluate efficacy of treatment plans
• Analyze ethical and legal implications related to prescribing therapy for clients with dementia

Learning Resources

Note: To access this week’s required library resources, please click on the link to the Course Readings List, found in the Course Materials section of your Syllabus.

Required Readings

Note: All Stahl resources can be accessed through this link provided.

Stahl, S. M. (2013). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). New York, NY: Cambridge University Press.

To access the following chapter, click on the Essential Psychopharmacology, 4th ed tab on the Stahl Online website and select the appropriate chapter. Be sure to read all sections on the left navigation bar for each chapter.

• Chapter 13, “Dementia and Its Treatment”

Stahl, S. M. (2014b). The prescriber’s guide (5th ed.). New York, NY: Cambridge University Press.

To access information on the following medications, click on The Prescriber’s Guide, 5th ed tab on the Stahl Online website and select the appropriate medication.

Review the following medications:

For insomnia

• donepezil
• galantamine
• memantine
• rivastigmine

Bui, Q. (2012). Antidepressants for agitation and psychosis in patients with dementia. American Family Physician, 85(1), 20–22. Retrieved from http://www.aafp.org/journals/afp.html

Note: Retrieved from from the Walden Library databases.

Meltzer, H. Y., Mills, R., Revell, S., Williams, H., Johnson, A., Bahr, D., & Friedman, J. H. (2010). Pimavanserin, a serotonin receptor inverse agonist for the treatment of Parkinson’s disease psychosis. Neuropsychopharmacology, 35, 881–891. Retrieved from http://www.nature.com/npp/journal/v35/n4/pdf/npp2009176a.pdf

Required Media

Laureate Education. (2016h). Case study: An elderly Iranian man with Alzheimer’s disease [Interactive media file]. Baltimore, MD: Author.Note: This case study will serve as the foundation for this week’s Assignment.

To prepare for this Assignment:

• Review this week’s Learning Resources. Consider how to assess and treat clients requiring therapy for dementia.

The Assignment

Examine Case Study: An Elderly Iranian Man With Alzheimer’s Disease.
You will be asked to make three decisions concerning the medication to
prescribe to this client. Be sure to consider factors that might impact
the client’s pharmacokinetic and pharmacodynamic processes.

• At each decision point stop to complete the following:
  • Decision #1
    • Which decision did you select?
    • Why did you select this decision? Support your response with evidence and references to the Learning Resources.
    • What were you hoping to achieve by making this decision?
      Support your response with evidence and references to the Learning
      Resources.
    • Explain any difference between what you expected to achieve
      with Decision #1 and the results of the decision. Why were they
      different?
  • Decision #2
    • Why did you select this decision? Support your response with evidence and references to the Learning Resources.
    • What were you hoping to achieve by making this decision?
      Support your response with evidence and references to the Learning
      Resources.
    • Explain any difference between what you expected to achieve
      with Decision #2 and the results of the decision. Why were they
      different?
  • Decision #3
    • Why did you select this decision? Support your response with evidence and references to the Learning Resources.
    • What were you hoping to achieve by making this decision?
      Support your response with evidence and references to the Learning
      Resources.
    • Explain any difference between what you expected to achieve
      with Decision #3 and the results of the decision. Why were they
      different?
• Also include how ethical considerations might impact your treatment plan and communication with clients.

Note: Support your rationale with a minimum of three
academic resources. While you may use the course text to support your
rationale, it will not count toward the resource requirement.

By Day 7

Submit your assignment

Submission and Grading Information

To submit your completed Assignment for review and grading, do the following:

• Please save your Assignment using the naming convention “WK10Assgn+last name+first initial.(extension)” as the name.
• Click the Week 10 Assignment Rubric to review the Grading Criteria for the Assignment.
• Click the Week 10 Assignment link. You will also be able to “View Rubric” for grading criteria from this area.
• Next, from the Attach File area, click on the Browse My Computer button. Find the document you saved as “WK10Assgn+last name+first initial.(extension)” and click Open.
• If applicable: From the Plagiarism Tools area, click the checkbox for I agree to submit my paper(s) to the Global Reference Database.
• Click on the Submit button to complete your submission.

Grading Criteria

To access your rubric:Week 10 Assignment Rubric

Check Your Assignment Draft for Authenticity

To check your Assignment draft for authenticity:Submit your Week 10 Assignment draft and review the originality report.

Submit Your Assignment by Day 7

To submit your Assignment:Week 10 Assignment

Making Connections

Now that you have:

• Assessed clients presenting with dementia
• Developed personalized plans of therapy for clients with dementia
• Examined factors that influence pharmacokinetic and pharmacodynamic processes in clients requiring therapy for dementia
• Explored ethical and legal implications of prescribing therapy to clients with dementia

Next week, you will build on your
assessment and treatment skills as you examine clients presenting for
therapy for comorbid conditions.
To go to the next week:Week 11

“